Breaking News Instant updates and real-time market news.

TBIO

Translate Bio

$37.75 /

-0.12 (-0.32%)

17:30
08/05/21
08/05
17:30
08/05/21
17:30

Translate Bio reports Q2 net income of $17.1M vs. net loss of $36.3M last year

Reports Q2 revenue $72.6M, consensus $31.81M. "Since we started our partnership with Sanofi in 2018, we have moved two mRNA vaccine candidates through preclinical development to investigational new drug (IND) application submission, and initiated Phase 1 clinical trials for COVID-19 and seasonal influenza. We have made significant progress in the development of our mRNA vaccines through this collaboration, demonstrating some of the key attributes of our mRNA platform, including speed, flexibility and scale," said Ronald Renaud, chief executive officer, Translate Bio. "This transaction is a validation of our mRNA platform and a testament to the talented Translate Bio team. Joining Sanofi will deepen our existing relationship, and we believe it will strengthen the team's ability to bring innovative and life-changing medicines to patients. Sanofi's diverse therapeutics portfolio can also further demonstrate the advantages of our technology in areas beyond vaccines, building on the pioneering work done over the last 10+ years at Translate Bio."Translate Bio ended the second quarter of 2021 with $667.2 million in cash, cash equivalents and investments and 75,343,712 shares of common stock outstanding. Collaboration revenue was $72.6 million and $16.3 million for the three months ended June 30, 2021 and 2020, respectively. Revenue was derived from the collaboration with Sanofi and is recorded as a percentage of the estimated transaction price based on the extent of progress toward completion. The transaction price increased in the three months ended June 30, 2021 compared to the same period in 2020 which resulted in an increase in revenue.

TBIO Translate Bio
$37.75 /

-0.12 (-0.32%)

08/04/21 Roth Capital
Translate Bio price target lowered to $38 from $45 at Roth Capital
08/03/21 B. Riley
Direct read to Arcturus from Translate Bio deal 'unwarranted,' says B. Riley
08/03/21 Brookline
Brookline reiterates Buy on Arcturus amid RNA focus following Translate Bio deal
08/03/21 Jefferies
Translate Bio downgraded to Hold from Buy at Jefferies

TODAY'S FREE FLY STORIES

Hot Stocks
Four Corners Property Trust acquires Caliber Collision portfolio for $7.2M » 18:26
09/21/21
09/21
18:26
09/21/21
18:26
FCPT

Four Corners Property Trust

$27.23 /

-0.11 (-0.40%)

Four Corners Property…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FCPT Four Corners Property Trust
$27.23 /

-0.11 (-0.40%)

FCPT Four Corners Property Trust
$27.23 /

-0.11 (-0.40%)

08/18/21
Fly Intel: Top five analyst downgrades
08/18/21 Raymond James
Four Corners Property Trust downgraded to Outperform from Strong Buy at Raymond James
08/18/21 Raymond James
Four Corners downgraded to Outperform from Strong Buy at Raymond James
12/16/20 Baird
Four Corners Property Trust reinstated with an Outperform at Baird
FCPT Four Corners Property Trust
$27.23 /

-0.11 (-0.40%)

Hot Stocks
Disney says 'Shang-Chi,' 'Jungle Cruise' to stream on Disney+ November 12 » 18:23
09/21/21
09/21
18:23
09/21/21
18:23
DIS

Disney

$171.17 /

-7.47 (-4.18%)

Disney said that, on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DIS Disney
$171.17 /

-7.47 (-4.18%)

DIS Disney
$171.17 /

-7.47 (-4.18%)

15:38 Today KeyBanc
Disney+ subscriber guidance 'a very modest incremental negative,' says KeyBanc
05:19 Today Daiwa
Disney initiated with a Buy at Daiwa
09/13/21 Stephens
Recent Apple TV+ news positive for Roku, says Stephens
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
DIS Disney
$171.17 /

-7.47 (-4.18%)

DIS Disney
$171.17 /

-7.47 (-4.18%)

DIS Disney
$171.17 /

-7.47 (-4.18%)

DIS Disney
$171.17 /

-7.47 (-4.18%)

Periodicals
McDonald's to significantly cut use of plastic in toys by 2025, Reuters reports » 18:22
09/21/21
09/21
18:22
09/21/21
18:22
MCD

McDonald's

$240.58 /

+1.56 (+0.65%)

McDonald's announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MCD McDonald's
$240.58 /

+1.56 (+0.65%)

MCD McDonald's
$240.58 /

+1.56 (+0.65%)

07/29/21 RBC Capital
McDonald's price target raised to $268 from $263 at RBC Capital
07/29/21 Truist
McDonald's price target raised to $266 from $255 at Truist
07/29/21 Wedbush
McDonald's price target raised to $270 from $265 at Wedbush
07/29/21 Stephens
McDonald's price target raised to $260 from $245 at Stephens
MCD McDonald's
$240.58 /

+1.56 (+0.65%)

MCD McDonald's
$240.58 /

+1.56 (+0.65%)

MCD McDonald's
$240.58 /

+1.56 (+0.65%)

MCD McDonald's
$240.58 /

+1.56 (+0.65%)

Hot Stocks
Rhythm granted authorization to market IMCIVREE in Great Britain » 18:17
09/21/21
09/21
18:17
09/21/21
18:17
RYTM

Rhythm Pharmaceuticals

$12.57 /

-0.04 (-0.32%)

Rhythm Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RYTM Rhythm Pharmaceuticals
$12.57 /

-0.04 (-0.32%)

RYTM Rhythm Pharmaceuticals
$12.57 /

-0.04 (-0.32%)

09/14/21 Goldman Sachs
Rhythm Pharmaceuticals assumed with Neutral from Sell at Goldman Sachs
08/04/21
Fly Intel: Top five analyst downgrades
08/04/21 Ladenburg
Rhythm Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
08/04/21 BofA
Rhythm Pharmaceuticals downgraded to Underperform from Neutral at BofA
RYTM Rhythm Pharmaceuticals
$12.57 /

-0.04 (-0.32%)

  • 05
    Feb
RYTM Rhythm Pharmaceuticals
$12.57 /

-0.04 (-0.32%)

Periodicals
Lululemon says Mirror CEO stepping down, CNBC reports » 18:17
09/21/21
09/21
18:17
09/21/21
18:17
LULU

Lululemon

$424.32 /

+4.35 (+1.04%)

Lululemon will begin the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LULU Lululemon
$424.32 /

+4.35 (+1.04%)

LULU Lululemon
$424.32 /

+4.35 (+1.04%)

09/17/21 Oppenheimer
Lululemon price target raised to $520 from $405 at Oppenheimer
09/10/21 Argus
Lululemon price target raised to $500 from $416 at Argus
09/10/21 UBS
Lululemon price target raised to $430 from $375 at UBS
09/09/21 Guggenheim
Lululemon price target raised to $475 from $450 at Guggenheim
LULU Lululemon
$424.32 /

+4.35 (+1.04%)

LULU Lululemon
$424.32 /

+4.35 (+1.04%)

LULU Lululemon
$424.32 /

+4.35 (+1.04%)

LULU Lululemon
$424.32 /

+4.35 (+1.04%)

Hot Stocks
CF Industries to restart ammonia plant at its Billingham complex » 18:12
09/21/21
09/21
18:12
09/21/21
18:12
CF

CF Industries

$48.99 /

+0.98 (+2.04%)

CF Industries Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CF CF Industries
$48.99 /

+0.98 (+2.04%)

CF CF Industries
$48.99 /

+0.98 (+2.04%)

08/20/21
Fly Intel: Top five analyst upgrades
08/20/21 HSBC
CF Industries upgraded to Buy from Hold at HSBC
08/17/21 Berenberg
CF Industries upgraded to Buy from Hold at Berenberg
07/08/21 RBC Capital
CF Industries price target raised to $57 from $52 at RBC Capital
CF CF Industries
$48.99 /

+0.98 (+2.04%)

CF CF Industries
$48.99 /

+0.98 (+2.04%)

CF CF Industries
$48.99 /

+0.98 (+2.04%)

Hot Stocks
Bristol-Myers' Celgene receives FDA orphan designation for luspatercept » 18:11
09/21/21
09/21
18:11
09/21/21
18:11
BMY

Bristol-Myers

$60.31 /

-0.19 (-0.31%)

According to a post on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$60.31 /

-0.19 (-0.31%)

BMY Bristol-Myers
$60.31 /

-0.19 (-0.31%)

09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/27/21 Mizuho
Bristol-Myers deal a positive signal about BridgeBio's BBP-398, says Mizuho
07/26/21 Truist
Bristol-Myers assumed with a Buy at Truist
BMY Bristol-Myers
$60.31 /

-0.19 (-0.31%)

BMY Bristol-Myers
$60.31 /

-0.19 (-0.31%)

BMY Bristol-Myers
$60.31 /

-0.19 (-0.31%)

BMY Bristol-Myers
$60.31 /

-0.19 (-0.31%)

Earnings
Oil-Dri awarded patent in Indonesia for mineral-based formulation » 18:09
09/21/21
09/21
18:09
09/21/21
18:09
ODC

Oil-Dri Corporation of America

$34.65 /

+0.11 (+0.32%)

Oil-Dri announces that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ODC Oil-Dri Corporation of America
$34.65 /

+0.11 (+0.32%)

Hot Stocks
Genzyme receives FDA orphan designation for anti-thymocyte globulin » 18:08
09/21/21
09/21
18:08
09/21/21
18:08
SNY

Sanofi

$48.24 /

+0.345 (+0.72%)

According to a post on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$48.24 /

+0.345 (+0.72%)

SNY Sanofi
$48.24 /

+0.345 (+0.72%)

09/20/21 Oppenheimer
Denali Therapeutics initiated with an Outperform at Oppenheimer
09/20/21 Citi
Citi says 'remain upbeat' on Pfizer Covid revenue despite mixed panel vote
09/14/21 Mizuho
Kadmon downgraded to Neutral from Buy at Mizuho
09/10/21 UBS
Kadmon downgraded to Neutral from Buy at UBS
SNY Sanofi
$48.24 /

+0.345 (+0.72%)

SNY Sanofi
$48.24 /

+0.345 (+0.72%)

SNY Sanofi
$48.24 /

+0.345 (+0.72%)

Hot Stocks
FedEx says anticipate similar level of headwinds in Q2 as experienced in Q1 » 18:05
09/21/21
09/21
18:05
09/21/21
18:05
FDX

FedEx

$252.08 /

+1.26 (+0.50%)

Says impact to operations…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FDX FedEx
$252.08 /

+1.26 (+0.50%)

FDX FedEx
$252.08 /

+1.26 (+0.50%)

09/17/21 UBS
FedEx price target lowered to $380 from $397 at UBS
09/17/21 Baird
FedEx sentiment too negative with favorable outlook, says Baird
09/13/21 KeyBanc
FedEx price target lowered to $350 from $370 at KeyBanc
09/13/21 Citi
FedEx price target lowered to $360 from $365 at Citi
FDX FedEx
$252.08 /

+1.26 (+0.50%)

FDX FedEx
$252.08 /

+1.26 (+0.50%)

FDX FedEx
$252.08 /

+1.26 (+0.50%)

FDX FedEx
$252.08 /

+1.26 (+0.50%)

Hot Stocks
Glaukos announces FDA orphan designation for treatment of corneal ulcers » 18:04
09/21/21
09/21
18:04
09/21/21
18:04
GKOS

Glaukos

$50.92 /

-0.93 (-1.79%)

According to a post on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GKOS Glaukos
$50.92 /

-0.93 (-1.79%)

GKOS Glaukos
$50.92 /

-0.93 (-1.79%)

09/15/21 Piper Sandler
Piper says Glaukos patent settlement doesn't ease reimbursement challenges
09/01/21 William Blair
CMS panel sides with Glaukos on all proposals, says William Blair
08/06/21 Piper Sandler
Glaukos price target lowered to $45 from $80 at Piper Sandler
07/28/21 Citi
Glaukos price target lowered to $52 from $94 at Citi
GKOS Glaukos
$50.92 /

-0.93 (-1.79%)

GKOS Glaukos
$50.92 /

-0.93 (-1.79%)

Hot Stocks
Allison Transmission and Jing-Jin Electric sign global partnership agreement » 18:02
09/21/21
09/21
18:02
09/21/21
18:02
ALSN

Allison Transmission

$35.25 /

-0.03 (-0.09%)

Allison Transmission and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALSN Allison Transmission
$35.25 /

-0.03 (-0.09%)

ALSN Allison Transmission
$35.25 /

-0.03 (-0.09%)

07/13/21 JPMorgan
JPMorgan sees opportunities in machinery, upgrades three to Overweight
06/01/21
Fly Intel: Top five analyst downgrades
05/31/21 Goldman Sachs
Allison Transmission downgraded to Sell from Buy at Goldman Sachs
04/21/21 Raymond James
Allison Transmission downgraded to Market Perform from Strong Buy at Raymond James
ALSN Allison Transmission
$35.25 /

-0.03 (-0.09%)

Hot Stocks
FedEx says U.S. parcel market will grow to 101M packages per day by 2022 » 18:02
09/21/21
09/21
18:02
09/21/21
18:02
FDX

FedEx

$252.08 /

+1.26 (+0.50%)

Says market projections…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDX FedEx
$252.08 /

+1.26 (+0.50%)

FDX FedEx
$252.08 /

+1.26 (+0.50%)

09/17/21 UBS
FedEx price target lowered to $380 from $397 at UBS
09/17/21 Baird
FedEx sentiment too negative with favorable outlook, says Baird
09/13/21 KeyBanc
FedEx price target lowered to $350 from $370 at KeyBanc
09/13/21 Citi
FedEx price target lowered to $360 from $365 at Citi
FDX FedEx
$252.08 /

+1.26 (+0.50%)

FDX FedEx
$252.08 /

+1.26 (+0.50%)

FDX FedEx
$252.08 /

+1.26 (+0.50%)

FDX FedEx
$252.08 /

+1.26 (+0.50%)

Periodicals
Blizzard's executive producer of Overwatch, to leave, Bloomberg says » 18:00
09/21/21
09/21
18:00
09/21/21
18:00
ATVI

Activision Blizzard

$73.06 /

-3.19 (-4.18%)

Blizzard…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATVI Activision Blizzard
$73.06 /

-3.19 (-4.18%)

ATVI Activision Blizzard
$73.06 /

-3.19 (-4.18%)

09/15/21 KeyBanc
EA's delay of Battlefield 2042 slight positive for Activision, says KeyBanc
09/15/21 Benchmark
EA shares reacting negatively to Battlefield 2042 delay rumors, says Benchmark
09/15/21 Truist
Battlefield 2042 delay would be 'modest negative' for EA, says Truist
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
ATVI Activision Blizzard
$73.06 /

-3.19 (-4.18%)

ATVI Activision Blizzard
$73.06 /

-3.19 (-4.18%)

ATVI Activision Blizzard
$73.06 /

-3.19 (-4.18%)

ATVI Activision Blizzard
$73.06 /

-3.19 (-4.18%)

Hot Stocks
FedEx says labor markets are biggest issue, driver of lower than expected result » 17:55
09/21/21
09/21
17:55
09/21/21
17:55
FDX

FedEx

$252.08 /

+1.26 (+0.50%)

COO Rajesh Subramaniam…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDX FedEx
$252.08 /

+1.26 (+0.50%)

FDX FedEx
$252.08 /

+1.26 (+0.50%)

09/17/21 UBS
FedEx price target lowered to $380 from $397 at UBS
09/17/21 Baird
FedEx sentiment too negative with favorable outlook, says Baird
09/13/21 KeyBanc
FedEx price target lowered to $350 from $370 at KeyBanc
09/13/21 Citi
FedEx price target lowered to $360 from $365 at Citi
FDX FedEx
$252.08 /

+1.26 (+0.50%)

FDX FedEx
$252.08 /

+1.26 (+0.50%)

FDX FedEx
$252.08 /

+1.26 (+0.50%)

FDX FedEx
$252.08 /

+1.26 (+0.50%)

Conference/Events
Morgan Stanley Australia health analysts hold analyst/industry conference call » 17:40
09/21/21
09/21
17:40
09/21/21
17:40

Australia Healthcare…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
GoodRx to hold an educational webinar » 17:29
09/21/21
09/21
17:29
09/21/21
17:29
GDRX

GoodRx

$46.30 /

+0.3 (+0.65%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GDRX GoodRx
$46.30 /

+0.3 (+0.65%)

GDRX GoodRx
$46.30 /

+0.3 (+0.65%)

09/14/21 Credit Suisse
GoodRx price target raised to $52 from $45 at Credit Suisse
08/31/21 Barclays
GoodRx upgraded to Overweight from Equal Weight at Barclays
08/13/21 Raymond James
GoodRx upgraded to Outperform from Market Perform at Raymond James
08/13/21 Raymond James
GoodRx upgraded to Outperform from Market Perform at Raymond James
GDRX GoodRx
$46.30 /

+0.3 (+0.65%)

  • 23
    Sep
GDRX GoodRx
$46.30 /

+0.3 (+0.65%)

GDRX GoodRx
$46.30 /

+0.3 (+0.65%)

GDRX GoodRx
$46.30 /

+0.3 (+0.65%)

Hot Stocks
Stitch Fix says opened up Freestyle to new-to-Stitch Fix customers » 17:29
09/21/21
09/21
17:29
09/21/21
17:29
SFIX

Stitch Fix

$35.40 /

-0.995 (-2.73%)

Says doubled UK business.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SFIX Stitch Fix
$35.40 /

-0.995 (-2.73%)

SFIX Stitch Fix
$35.40 /

-0.995 (-2.73%)

09/15/21 MKM Partners
Stitch Fix price target lowered to $31 from $45 at MKM Partners
06/08/21 Canaccord
Stitch Fix price target raised to $76 from $68 at Canaccord
06/08/21 Truist
Stitch Fix price target raised to $77 from $60 at Truist
06/08/21 MKM Partners
Stitch Fix price target raised to $45 from $29 at MKM Partners
SFIX Stitch Fix
$35.40 /

-0.995 (-2.73%)

SFIX Stitch Fix
$35.40 /

-0.995 (-2.73%)

SFIX Stitch Fix
$35.40 /

-0.995 (-2.73%)

SFIX Stitch Fix
$35.40 /

-0.995 (-2.73%)

Earnings
BioDelivery Sciences sees Q3 revenue $38M-$42M, consensus $44.07M » 17:25
09/21/21
09/21
17:25
09/21/21
17:25
BDSI

BioDelivery Sciences

$4.02 /

+0.12 (+3.08%)

BioDelivery Sciences said…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BDSI BioDelivery Sciences
$4.02 /

+0.12 (+3.08%)

BDSI BioDelivery Sciences
$4.02 /

+0.12 (+3.08%)

05/06/21 Roth Capital
BioDelivery Sciences price target lowered to $6.25 from $7 at Roth Capital
03/11/21 H.C. Wainwright
BioDelivery Sciences price target lowered to $5.50 from $7 at H.C. Wainwright
BDSI BioDelivery Sciences
$4.02 /

+0.12 (+3.08%)

Hot Stocks
Incyte trading resumes  17:25
09/21/21
09/21
17:25
09/21/21
17:25
INCY

Incyte

$76.03 /

+0.12 (+0.16%)

 
ShowHide Related Items >><<
INCY Incyte
$76.03 /

+0.12 (+0.16%)

INCY Incyte
$76.03 /

+0.12 (+0.16%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/09/21 Benchmark
Sanofi deal for Kadmon reinforces Incyte thesis, says Benchmark
09/01/21 Cowen
Odds of Incyte drug exclusion from class warning 'largely unchanged,' says Cowen
07/20/21 Benchmark
Incyte upgraded to Buy from Hold at Benchmark
INCY Incyte
$76.03 /

+0.12 (+0.16%)

INCY Incyte
$76.03 /

+0.12 (+0.16%)

INCY Incyte
$76.03 /

+0.12 (+0.16%)

INCY Incyte
$76.03 /

+0.12 (+0.16%)

Hot Stocks
Greenbrook TMS Inc trading resumes  17:25
09/21/21
09/21
17:25
09/21/21
17:25
GBNH

Greenbrook TMS

$9.43 /

+0.96 (+11.33%)

 
ShowHide Related Items >><<
GBNH Greenbrook TMS
$9.43 /

+0.96 (+11.33%)

GBNH Greenbrook TMS
$9.43 /

+0.96 (+11.33%)

07/08/21 Desjardins
Greenbrook TMS resumed with a Buy at Desjardins
  • 22
    Sep
Syndicate
Warner Music 2.43M share Spot Secondary; price range $44.00-$45.00 » 17:24
09/21/21
09/21
17:24
09/21/21
17:24
WMG

Warner Music

$44.96 /

+4.72 (+11.73%)

Morgan Stanley is acting…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WMG Warner Music
$44.96 /

+4.72 (+11.73%)

WMG Warner Music
$44.96 /

+4.72 (+11.73%)

09:54 Today
Fly Intel: Top five analyst upgrades
06:12 Today Credit Suisse
Warner Music upgraded to Outperform on streaming growth at Credit Suisse
06:07 Today Credit Suisse
Warner Music upgraded to Outperform from Neutral at Credit Suisse
08/17/21 Tigress Financial
Warner Music price target raised to $48 from $42 at Tigress Financial
WMG Warner Music
$44.96 /

+4.72 (+11.73%)

  • 22
    Sep
  • 09
    Sep
  • 09
    Dec
WMG Warner Music
$44.96 /

+4.72 (+11.73%)

WMG Warner Music
$44.96 /

+4.72 (+11.73%)

Hot Stocks
BioDelivery Sciences warns of payer issues around BELBUCA coverage » 17:24
09/21/21
09/21
17:24
09/21/21
17:24
BDSI

BioDelivery Sciences

$4.02 /

+0.12 (+3.08%)

BioDelivery Sciences said…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BDSI BioDelivery Sciences
$4.02 /

+0.12 (+3.08%)

BDSI BioDelivery Sciences
$4.02 /

+0.12 (+3.08%)

05/06/21 Roth Capital
BioDelivery Sciences price target lowered to $6.25 from $7 at Roth Capital
03/11/21 H.C. Wainwright
BioDelivery Sciences price target lowered to $5.50 from $7 at H.C. Wainwright
BDSI BioDelivery Sciences
$4.02 /

+0.12 (+3.08%)

Conference/Events
PTC Therapeutics to hold a conference call » 17:24
09/21/21
09/21
17:24
09/21/21
17:24
PTCT

PTC Therapeutics

$43.59 /

+1.99 (+4.78%)

Conference call to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PTCT PTC Therapeutics
$43.59 /

+1.99 (+4.78%)

PTCT PTC Therapeutics
$43.59 /

+1.99 (+4.78%)

08/31/21 UBS
PTC Therapeutics price target lowered to $45 from $55 at UBS
05/17/21 Truist
PTC Therapeutics price target lowered to $65 from $75 at Truist
04/26/21 Credit Suisse
PTC Therapeutics assumed with a Neutral at Credit Suisse
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
PTCT PTC Therapeutics
$43.59 /

+1.99 (+4.78%)

PTCT PTC Therapeutics
$43.59 /

+1.99 (+4.78%)

Hot Stocks
Bitcoin extends decline below $40,000, lowest level since August 4th  17:22
09/21/21
09/21
17:22
09/21/21
17:22
BTC

Bitcoin

/

+

, $BTC

Bitcoin

/

+

 
ShowHide Related Items >><<
BTC Bitcoin
/

+

$BTC Bitcoin
/

+

BTC Bitcoin
/

+

09/08/21 Cowen
SEC's Coinbase action likely a broader crackdown on crypto lending, says Cowen
08/03/21 Craig-Hallum
Craig-Hallum bullish on Hut 8 Mining, initiates with a Buy
04/27/21 Roth Capital
Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital
04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
$BTC Bitcoin
/

+

09/08/21 Cowen
SEC's Coinbase action likely a broader crackdown on crypto lending, says Cowen
08/03/21 Craig-Hallum
Craig-Hallum bullish on Hut 8 Mining, initiates with a Buy
04/27/21 Roth Capital
Regulatory credits, bitcoin fuel Tesla Q1 headline beat, says Roth Capital
04/15/21 Morgan Stanley
WisdomTree Bitcoin ETP cross-listing could speed up growth, says Morgan Stanley
BTC Bitcoin
/

+

$BTC Bitcoin
/

+

BTC Bitcoin
/

+

$BTC Bitcoin
/

+

BTC Bitcoin
/

+

$BTC Bitcoin
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.